Dysphonia and Dyspnea in Idiopathic Hypereosinophilic Syndrome Treated with Mepolizumab

被引：0
|
作者：
Kay, D. [1 ]
Ataya, A. [1 ]
Urbine, D. R. [1 ]
机构：
[1] Univ Florida, Pulm & Crit Care, Gainesville, FL USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2997
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Anti-IL-5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of idiopathic hypereosinophilic syndrome (HES)
    Rondoni, M.
    Paolini, S.
    Ottaviani, E.
    Piccaluga, P. P.
    Papayannidis, C.
    Giannoulia, F.
    De Rosa, F.
    Laterza, C.
    Cilloni, D.
    Baccarani, M.
    Martinelli, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 26 - 27
  • [42] Impact of Baseline Blood Eosinophil Count on Flare Reduction in Mepolizumab-Treated Patients With Hypereosinophilic Syndrome
    Rothenberg, Marc
    Roufosse, Florence
    Faguer, Stanislas
    Gleich, Gerald
    Kahn, Jean-Emmanuel
    Steinfeld, Jonathan
    Kwon, Namhee
    Bentley, Jane
    Yancey, Steve
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB139 - AB139
  • [43] Mepolizumab-a novel option for the treatment of hypereosinophilic syndrome in childhood
    Schwarz, Carsten
    Mueller, Thilo
    Lau, Susanne
    Parasher, Kirn
    Staab, Doris
    Wahn, Ulrich
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2018, 29 (01) : 28 - 33
  • [44] Characterization of disease flares and impact of mepolizumab in patients with hypereosinophilic syndrome
    Pane, Fabrizio
    Lefevre, Guillaume
    Kwon, Namhee
    Bentley, Jane H.
    Yancey, Steven W.
    Steinfeld, Jonathan
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [45] Mepolizumab in Hypereosinophilic Syndrome: A Systematic Review and Meta-analysis
    Alves Junior, Jose Mario
    Prota, Francisco Eduardo
    Villagelin, Danilo
    Bley, Fernanda
    Bernardo, Wanderley Marques
    CLINICS, 2021, 76
  • [46] Hypereosinophilic syndrome response to mepolizumab in the setting of a compassionate use program
    Coussement, Gauthier
    Catherine, Julien
    Roufosse, Florence
    JOURNAL OF LEUKOCYTE BIOLOGY, 2024, 116 (05) : 1021 - 1032
  • [47] Observational Experience Describing The Use Of Mepolizumab In Patients With Hypereosinophilic Syndrome
    Duncan, E. A.
    Ortega, H.
    Gleich, G.
    Price, R.
    Yancey, S.
    Klion, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [48] Mepolizumab as a management strategy for hypereosinophilic syndrome: experience of a tertiary hospital
    Ferreira, Sofia Cosme
    Gomes, Margarida
    Mendes, Ana
    Pedro, Elisa
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB65 - AB65
  • [49] Wells' syndrome associated with idiopathic hypereosinophilic syndrome
    Bogenrieder, T
    Griese, DP
    Schiffner, R
    Büttner, R
    Riegger, GAJ
    Hohenleutner, U
    Landthaler, M
    BRITISH JOURNAL OF DERMATOLOGY, 1997, 137 (06) : 978 - 982
  • [50] NEUROLOGIC DYSFUNCTION IN THE IDIOPATHIC HYPEREOSINOPHILIC SYNDROME
    MOORE, PM
    HARLEY, JB
    FAUCI, AS
    ANNALS OF INTERNAL MEDICINE, 1985, 102 (01) : 109 - 114
12345